Oezguen, N. Et Al. 2022. Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios. MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.68 .

Oezguen, N., Yılmaz, V., Horvath, T. D., Akbayir, E., Haidacher, S. J., Hoch, K. M., ... Thapa, S.(2022). Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios. MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.68.

Oezguen, Numan Et Al. "Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios," MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.68, 2022

Oezguen, Numan Et Al. "Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios." MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.68, 2022

Oezguen, N. Et Al. (2022) . "Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios." MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.68.

@article{article, author={Numan Oezguen Et Al. }, title={Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios}, journal={MULTIPLE SCLEROSIS AND RELATED DISORDERS}, year=2022}